Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor

about

Weight reduction and pioglitazone ameliorate polycystic ovary syndrome after removal of a Sertoli-stromal cell tumor

Item

http://www.wikidata.org/entity/Q36444384

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@ast

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@en

type

Item

label

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@ast

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@en

prefLabel

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@ast

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@en

P1476

Weight reduction and pioglitaz ...... f a Sertoli-stromal cell tumor

@en

P2093

Ayumi Shimizu

http://www.w3.org/2001/XMLSchema#string

Keiko Ikeda

http://www.w3.org/2001/XMLSchema#string

Miyuki Morishita

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Ishioka

http://www.w3.org/2001/XMLSchema#string

Tamotsu Kiya

http://www.w3.org/2001/XMLSchema#string

Toshiaki Endo

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Baba

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Saito

http://www.w3.org/2001/XMLSchema#string

Yoshika Kuno

http://www.w3.org/2001/XMLSchema#string

P2860

Lifestyle changes in women with polycystic ovary syndrome

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.

Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Development of polycystic ovary syndrome: involvement of genetic and environmental factors.

Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.

Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population.

P304

607-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/IJWH.S36667

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroyuki Honnma

P577

2012-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23226075

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

3514067

http://www.w3.org/2001/XMLSchema#string